ExlService Holdings, Inc. (EXLS)
UnterbewertetFundamental
76
Kurs
$34.38
Marktkapitalisierung
$5.25B
Teil 1 · Was das Unternehmen wert ist
Übersicht
ExlService Holdings (EXL) is a data and artificial-intelligence company that runs analytics and business processes on behalf of other companies. It sells two broad things: data and AI-led solutions — analytics, data management and digital engineering embedded into a client's workflow — and digital operations, meaning technology-enabled managed services where EXL takes over a repetitive back-office process such as insurance claims handling, healthcare payment integrity or finance and accounting. The work is delivered mostly from low-cost locations: of more than 65,000 employees at the end of 2025, roughly 43,200 were in India, 13,400 in the Philippines, 4,100 in South Africa and only about 2,900 in the United States, across 50-plus offices on six continents. Clients are concentrated in insurance, healthcare and life sciences, banking and capital markets; the company served approximately 590 clients in 2025.
Wie das Geld verdient wird
EXL sells services under master services agreements supplemented by individual statements of work. The mix runs from project-based engagements, typically shorter than a year, to long-term digital operations contracts that usually run three to five years. Revenue therefore arrives partly as recurring fees for running a process and partly as project fees for analytics and engineering work that must be re-won. There is no product licence and no hardware: revenue is essentially people and technology billed to the client, which is why employee costs and wage inflation sit at the centre of the margin story. In 2025 revenue was $2.09 billion, up 13.6% from $1.84 billion in 2024.
Umsatz nach Segment
Analytics and managed operations for property and casualty and life insurers: underwriting support, claims handling, subrogation and actuarial analytics. Revenue was $710.6 million in 2025, up 8.3% year on year — the largest segment but the slowest grower.
Services for health payers, providers and pharmaceutical companies — payment integrity, care management analytics and commercial analytics for drugmakers. Revenue was $532.5 million in 2025, up 23.6%, the fastest-growing segment.
Data, analytics and operations for banks, asset managers and non-financial corporates, including finance and accounting outsourcing and customer operations. Revenue was $482.4 million in 2025, up 13.0%.
Clients outside EXL's core United States base — the United Kingdom, Europe, Australia and other markets — served across the same industry offerings. Revenue was $362.2 million in 2025, up 11.6%.
Wettbewerbsvorteil
Wechselkosten · SchmalOnce EXL is running a client's claims queue or payment-integrity process under a three-to-five-year contract, the client has handed over trained staff, workflow knowledge and data pipelines; moving the work back in-house or to a rival is slow and disruptive, which is what keeps the long-term operations contracts sticky. That stickiness is real but narrow: EXL competes against much larger Indian and global IT-services firms on work that is ultimately labour arbitrage plus domain expertise, the contracts come up for renewal and reprice, and generative AI cuts both ways — it can raise the value EXL adds, or let a client do the same work with fewer outsourced people. The company's own filing warns that use of AI technology presents competitive, reputational and legal risks and may not be successful.
Was die Nachfrage antreibt
Mäßig zyklischTwo different demands sit inside one company. The digital operations contracts run three to five years and cover work a client cannot stop doing — claims still have to be paid, invoices still have to be processed — so that revenue holds up through a downturn, and a recession can even push more work offshore as clients hunt for cost savings. The analytics and AI projects behave differently: they are discretionary technology budget, often under a year, and they are the first line item a client can defer when spending is cut. EXL itself flags that demand depends on anticipating the latest technology and can be affected by selling cycles. The result is a business that is steadier than pure consulting but more exposed than a regulated utility, with the sector mix — insurers and health payers, both defensive buyers — cushioning the swing.
Wichtigste Risiken
- Demand and keeping up with technology — The company states that its business depends on maintaining and growing client demand for its services and solutions, including by anticipating and incorporating the latest technology into its offerings; a significant reduction in that demand, a failure to respond to the evolving technological environment, or a change in how it delivers its services could materially affect results of operations.
- The AI bet may not work — EXL discloses that the use of AI technology presents competitive, reputational and legal risks and that its use of AI technology may not be successful. It notes that the domestic and international legal and regulatory landscape around AI is rapidly evolving and uncertain, including on intellectual property, cybersecurity, and privacy and data protection.
- Selling cycles and contract terms — The company warns that client demand may be impacted by the selling cycle and by the terms of its client contracts, including for its AI-related offerings — a reminder that signed work can be slow to convert into revenue and that contract terms sit with the buyer.
- Hiring and retaining people — EXL states that it may fail to attract and retain enough sufficiently trained employees to support its operations, or professionals with sufficient leadership capabilities. With more than 65,000 employees, the workforce is the product being sold.
- Wage increases squeeze the margin — The filing states that employee wage increases may prevent the company from sustaining its competitive advantage and may reduce its profit margin. Because the model rests on delivering from lower-cost locations, wage inflation in India and the Philippines erodes the gap the client is paying for.
- Taxes, repatriation and cross-border regulation — The company warns that its financial condition could be negatively affected if governments in the countries where it operates introduce unfavourable tax legislation, including legal restrictions on repatriating earnings, and that its global operations subject it to numerous legal and regulatory requirements, including accreditation or licensing standards governing its business.
Kundenkonzentration
Die größten Kunden machen 34 % des Umsatzes aus
The 10-K discloses that the top ten clients accounted for 34.0% of revenues in 2025, the top five for 23.9% and the top three for 17.8%, with no single client representing more than 10% of total revenues. The company served approximately 590 clients, each with annual revenue above $50,000. So the tail is long and no one customer can sink the year, but a third of the business still sits with ten relationships — losing or repricing one of them is felt.
Die Argumente dafür
Buyers argue that EXL sits on the right side of the AI shift rather than in front of it: it already holds the client's data and runs the workflow, so the tools that automate that work are tools EXL can sell back into an account it controls. They point to 2025 revenue of $2.09 billion, up 13.6%, with adjusted diluted earnings per share up 18.0% to $1.95, and to healthcare and life sciences growing 23.6% — evidence, they say, that the mix is tilting toward the faster, higher-value end rather than toward commodity back-office. They add that no client exceeds 10% of revenue, that the long-term operations contracts renew rather than have to be re-won each year, and that management guided 2026 revenue to $2.275–2.315 billion, 9–11% growth, while authorising a $500 million buyback over two years.
Die Argumente dagegen
Sellers fear that the same technology feeding the growth story eventually eats the revenue line. The company bills for people — over 65,000 of them, some 43,200 in India — and if generative AI does what its promoters claim, the client needs fewer of those people for the same outcome, which shows up as price pressure at renewal rather than as lost logos. EXL's own filing concedes that its use of AI technology presents competitive, reputational and legal risks and may not be successful, and that employee wage increases may prevent it from sustaining its competitive advantage and may reduce its profit margin — the pincer sellers point to: costs rising in India while pricing falls. They also note that the largest segment, insurance at 34.0% of 2025 revenue, grew only 8.3%, slower than the group; that the analytics work is discretionary budget with long selling cycles the company itself flags; and that the delivery model concentrates operational, tax and repatriation exposure in a handful of emerging-market jurisdictions.
Generated on 18. September 2026 with claude-haiku-4-5 — shared with all users
Direct competitors
Who this company fights with for the same customers
Generated on 18. September 2026 with claude-haiku-4-5 — shared with all users
Listed among EXL's large global competitors, Cognizant bids for the same insurance, banking and healthcare-payer contracts covering claims, policy administration and analytics work.
Named by EXL in its own 10-K, Genpact is the closest like-for-like rival: both sell offshore-delivered digital operations plus data and AI services to insurers, banks and healthcare payers from the same India-centric delivery base.
Capgemini is named as a competitor in EXL's 10-K and, having absorbed WNS in October 2025, it now also owns EXL's historic head-to-head rival in insurance and banking process outsourcing.
Named in EXL's 10-K, Accenture chases the same corporate budgets for operations outsourcing and AI-led transformation, usually entering through consulting and then taking over the running of the process.
Named by EXL as a niche competitor, Cotiviti sells payment integrity and clinical analytics to the same US health insurers that buy EXL's healthcare offering; it is privately held by Veritas Capital and KKR.
Named in EXL's 10-K, Infosys competes through Infosys BPM for the same outsourced finance, insurance and customer-operations contracts, bundling them with its IT services relationships.
Bilanz & Liquidität
Umsatz
$2.16B
Letzte 12 Monate (bis 31.3.2026)
Nettogewinn
$252M
Letzte 12 Monate (bis 31.3.2026)
Freier Cashflow
$298M
Gesamtes Eigenkapital
$913M
Gesamtverbindlichkeiten
$790M
Current Ratio
2.66
Zinsdeckungsgrad
18.78
Schulden/EBITDA
1.40
Gewinn je Aktie
Umsatz & Nettogewinn
Freier Cashflow
Ertragsaufschlüsselung
Historische Aufstellung
Margen im Zeitverlauf
Verschuldung im Zeitverlauf
Wie schwer die Schulden wiegen
Wachstumsraster
Wachstum — Umsatz
Innerer-Wert-Schätzung
Innerer Wert
$52.72
Aktueller Kurs
$34.38
Sicherheitsmarge
+34.8%
Innerer-Wert-Spanne
$34.27 - $71.17
Streubreite zwischen den verwendeten Bewertungsmethoden, kein statistisch kalibriertes Konfidenzintervall.
Bewertungsmethoden
Bewertungskennzahlen
P/E-Verhältnis
21.90
ROE
27.5%
P/B-Verhältnis
6.74
P/FCF
17.71
Bruttomarge
38.5%
ROIC
18.8%
Rentabilitäts-Radar
Wertschöpfung (Wettbewerbsvorteil)
ROIC
18.8%
WACC
8.7%
ROIC − WACC
+10.1 pp
Der ROIC übersteigt die Kapitalkosten: Das Unternehmen schafft Wert für die Aktionäre.
Fundamentalanalyse-Kriterien
Bestanden (23)
- EPS shows upward trend
- EPS CAGR 6.89%
- Price CAGR 13.19%
- ROIC 18.8%
- Gross Margin 38.5%
- P/FCF 17.71
- Debt/Equity ratio
- Operating Margin 15.2%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 28.5%
- Revenue Growth 5Y 16.9%
- Analyst Consensus 94% Buy
- Earnings Surprise avg 4.7%
- PEG Ratio 0.86
- Earnings Quality (OCF/NI) 1.39
- Share Dilution -0.5%
- Net Margin Trend 11.7% vs 11.4%
- Piotroski F-Score 7/9
Nicht bestanden (4)
- P/B Ratio 6.74
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
Nicht verfügbar (1)
- Dividend Payout NaN%
Piotroski F-Score
Starke finanzielle Gesundheit
Gewinnqualität
Hohe Qualität: Gewinne durch Cashflow gedeckt
Aktienverwässerung
Aktienrückkäufe. Aktionärsfreundlich
Institutionelle Beteiligungen
Unternehmensführung
Führungsteam
| Name | Position | Alter |
|---|---|---|
| Mr. Rohit Kapoor | Co-Founder, Chairman & CEO | 60 |
| Mr. Vikas Bhalla | President and Head of AI Services & Operations | 53 |
| Mr. Vivek Jetley | President and Head of Insurance, Healthcare & Life Sciences | 50 |
| Mr. Maurizio Nicolelli CPA | Executive VP & CFO | 57 |
| Mr. Narasimha Kini | Executive Vice President of Banking & Capital Markets and Diversified Industries | 56 |
| Ms. Bhavna Newle Chopra | Senior Vice President in Operations Management | - |
| Mr. Baljinder Singh | Executive VP, Global Chief Information Officer & Head of Enterprise Digital Transformation | 52 |
| Mr. Andrew Thut | Head of Investor Relations & Capital Markets | - |
| Mr. Ajay Ayyappan J.D. | Executive VP, General Counsel & Corporate Secretary | 47 |
| Mr. Joel Katz | Senior VP and Chief Compliance & Ethics Officer | - |
Prüfungsrisiko
1
Vorstandsrisiko
5
Vergütungsrisiko
1
Aktionärsrechterisiko
4
Teil 2 · Der Preis und der Einstiegszeitpunkt
Dieser Teil sagt nicht, ob das Unternehmen etwas taugt: Er hilft bei der Wahl des Kaufzeitpunkts, nachdem die Fundamentaldaten überzeugt haben. Enthalten: technische Analyse, Potenzial, historische Drawdowns, Gamma-Exposure.
Dokumente
- Dokument ansehen
Jahresbericht (10-K)
Ein jährlicher Überblick über das Geschäft, die Finanzergebnisse und die Risiken des Unternehmens.
Eingereicht am 2026-02-24
- Dokument ansehen
Quartalsbericht (10-Q)
Ein Update zur finanziellen Entwicklung der letzten drei Monate.
Eingereicht am 2026-07-28
- Dokument ansehen
Ad-hoc-Meldung (8-K)
Eine Mitteilung über ein wichtiges Ereignis, etwa einen Führungswechsel oder eine bedeutende Ankündigung.
Eingereicht am 2026-09-02
via SEC EDGAR
Ertragshistorie
via SEC EDGAR
Latest News
Recent headlines for EXLS, sourced from Markets Gazette.
- 3/11/2026NEGATIVEEXL Stock Down 41% Year Over Year as One Investor Reveals $68 Million Exit
ExlService Holdings Inc. (EXLS) has experienced a significant 41% decline in its stock value over the past year. This downturn is highlighted by a substantial $68 million exit by a key investor, signaling a potential loss of confidence or a strategic shift. The company, which provides digital operations and analytics solutions to the insurance, healthcare, and life sciences sectors, faces increased scrutiny from the market. Investors are likely reassessing the company's growth prospects and competitive positioning in light of this exit and the substantial share price depreciation.
- 2/25/2026NEUTRALExlService (EXLS) Q4 2025 Earnings Call Transcript
Investors in ExlService (EXLS) are currently awaiting the release of the transcript from the company's fourth-quarter 2025 earnings call. While the event has been announced, specific details regarding key financial metrics such as revenue, earnings per share, and future guidance are not yet available. The market will closely scrutinize this information to assess the company's performance during the period and its growth prospects. The absence of concrete data currently prevents a directional judgment on the potential impact these results might have on the stock. The reaction of EXLS shares will entirely depend on the strength of the numbers presented and the future projections outlined by management.
via Markets Gazette